GSK Headquarters: London, United Kingdom Number of employees: 65,000 Year founded: 2000 Revenue (2025): $40.1 billion Forbes overall rank: 57 GSK company reported ~31.4 billion ($41.9 billion) in annual 2025 sales driven by strong growth in its specialty medicines and vaccines portfolios, including HIV therapies such as Dovato (dolutegravir/lamivudine) and Cabenuva (cabotegravir/rilpivirine), the blockbuster RSV vaccine Arexvy (respiratory syncytial virus vaccine, adjuvanted) and expanding oncology products like Jemperli (dostarlimab-gxly)
doi: 10.1146/annurev.nutr.22.012502.114457 105 HelmanS
Still have it...
Double glutathione body milk by AILKE BOOST LUSTET is developed for black skin and dark skin, the lotion is very delicate, easy to absorb, soft as feathers 2
BPC-157 + CJC-1295 + Ipamorelin: Longevity and Body Composition For patients focused on body composition, longevity, and performance optimisation, adding CJC-1295 and Ipamorelin to a BPC-157 protocol creates a powerful synergy
Bacteria changes may be linked to geographic location where the study was carried